This search looks for keywords in all of the website’s content. Search tips
Filter by
- Agenda(145)
- Annex to CHMP highlights(0)
- Annual Report(0)
- Application withdrawal assessment report(0)
- Committee meeting report(175)
- COVID-19 vaccine safety update(0)
- Direct healthcare professional communication(1)
- EPAR - All authorised presentations(0)
- EPAR - Amended Product Information(0)
- EPAR - Assessment report - Variation(1)
- EPAR - Assessment report on maintenance of orphan designation - Initial authorisation(0)
- EPAR - Assessment report on maintenance of orphan designation - Post-authorisation(0)
- EPAR - Conditions imposed on member states for safe and effective use(0)
- EPAR - Overview(0)
- EPAR - Paediatric investigation plan compliance statement(2)
- EPAR - Procedural steps taken and scientific information after authorisation(0)
- EPAR - Procedural steps taken before authorisation(0)
- EPAR - Product Information(0)
- EPAR - Public assessment report(0)
- EPAR - Risk-management-plan summary(0)
- EPAR - Scientific conclusion(0)
- EPAR - Scientific Discussion(0)
- EPAR - Scientific Discussion - Variation(0)
- EPAR - Steps taken after authorisation when a cutoff date has been used(0)
- Herbal - Call for data(0)
- Herbal - Herbal monograph(0)
- Herbal - HMPC assessment report(2)
- Herbal - HMPC opinion on a European Union herbal monograph(0)
- Herbal - List of references supporting the assessment report(2)
- Herbal - Overview of comments received during consultation(0)
- Herbal - Summary of assessment report for the public(0)
- Herbal – European Union herbal monograph(0)
- Herbal – European Union list entry(0)
- Leaflet(0)
- Maximum Residue Limits - Divergent opinion(0)
- Maximum Residue Limits - Opinion(0)
- Maximum Residue Limits - Report(0)
- Maximum Residue Limits - Summary of opinion(0)
- Medicine QA(0)
- Medicines under additional monitoring(0)
- Minutes(139)
- Newsletter(0)
- Opinion outside EU - All presentations(0)
- Opinion outside EU - Assessment report - Variation(0)
- Opinion outside EU - Medicine questions and answers(0)
- Opinion outside EU - Procedural steps taken and scientific information after opinion(0)
- Opinion outside EU - Procedural steps taken before opinion(0)
- Opinion outside EU - Product information(0)
- Opinion outside EU - Public assessment report(0)
- Opinion outside EU - Risk-management-plan summary(0)
- Opinion outside EU - Scientific discussion(0)
- Opinion outside EU - Summary for the public(0)
- Opinion outside EU - Summary of opinion(0)
- Opinion outside EU - Summary of opinion - Initial authorisation(0)
- Opinion outside EU - Withdrawal assessment report(0)
- Orphan designation(50)
- Orphan review(0)
- Other(159)
- Overview of comments(2)
- Parallel distribution(0)
- Periodic safety update single assessment(14)
- PIP - Notification of discontinuation of a paediatric development which is covered by an agreed PIP decision(62)
- PIP - Paediatric-investigation-plan summary(92)
- PIP decision(5220)
- Position statement(0)
- PRAC recommendation on signal(0)
- Presentation(149)
- Press Release(32)
- Procurement(0)
- Public Statement(2)
- Recommendation on medication errors(0)
- Recruitment(0)
- Referrals document(0)
- Regulatory and procedural guideline(11)
- Report(5)
- Scientific guideline(5)
- Standard Operating Procedure - SOP(0)
- Summary of opinion(0)
- Summary of opinion - Initial authorisation(0)
- Supply shortage(0)
- Template or form(4)
- Withdrawal letter(0)
- Work Instruction - WIN(0)
- Work programme(5)
- Advanced therapies(24)
- Antimicrobial resistance(0)
- Biologicals(0)
- Biosimilars(1)
- Brexit(28)
- Careers(0)
- Clinical trials(0)
- Compassionate use(0)
- Compliance and inspections(4)
- Corporate(1)
- COVID-19(21)
- Data on medicines(8)
- Early access(0)
- Fees(0)
- Generic and hybrid medicines(4)
- Governance(2)
- Innovation(7)
- Maximum residue limit(0)
- Medication error(0)
- Medicines(4032)
- Medicines for use outside the EU(0)
- Medicine shortages(1)
- Mpox(0)
- Paediatrics(6462)
- Parallel distribution(0)
- Pharmacovigilance(28)
- Procurement(0)
- Product information(108)
- Quality of medicines(2)
- Rare diseases(114)
- Referrals(45)
- Regulatory and procedural guidance(69)
- Research and development(5)
- Scientific advice(0)
- Scientific guidelines(1)
- SME(1)
- Vaccines(52)
- Veterinary limited markets(0)
Search results (6550)
Agenda - PDCO agenda of the 28-31 May 2024 meeting
English (EN) (364.11 KB - PDF)
P/0480/2023 : EMA decision of 1 December 2023 on the agreement of a paediatric investigation plan and on the granting of a deferral for cobolimab (EMEA-003273-PIP02-22)
English (EN) (210.4 KB - PDF)
P/0422/2023 : EMA decision of 27 October 2024 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for fazirsiran (EMEA-003355-PIP01-22)
English (EN) (235.52 KB - PDF)
P/0411/2023 : EMA decision of 25 October 2023 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for deucrictibant (EMEA-003090-PIP02-22)
English (EN) (319.28 KB - PDF)
PDCO minutes of the 19-22 March 2024 meeting
English (EN) (1.54 MB - PDF)
P/0559/2021 : EMA decision of 27 December 2021 on the acceptance of a modification of an agreed paediatric investigation plan for COVID-19 vaccine (ChAdOx1-S [recombinant]) (Vaxzevria), (EMEA-002862-PIP01-20-M02)
English (EN) (791.47 KB - PDF)
Agenda - PDCO agenda of the 23-26 April 2024 meeting
English (EN) (1.12 MB - PDF)